Target intelligence / Profile preview

Retinoblastoma binding protein 6 pseudogene (null)

Target: null
Molecular classification: Other (pseudogene; not enzyme, receptor, transporter, etc.)

Overview

The retinoblastoma binding protein 6 pseudogene refers to one of several non-functional gene copies related to the protein-coding RBBP6 gene, which encodes a ubiquitin ligase involved in cell cycle regulation, apoptosis, and cancer biology[1][3][5][6]. Pseudogenes such as ENSG00000277981 do not produce a functional protein and are typically not expressed or only transcribed at low levels without known biological or disease-related activity. Only the protein-coding RBBP6 (ENSG00000122257) is considered a biologically relevant molecule and potential pharmacologic target[1][3][5][6]. ENSG00000277981 is a pseudogene—not a protein-coding gene, receptor, or drug target. The true target (should one seek a molecular function or therapeutic relevance) is retinoblastoma binding protein 6 (RBBP6), not the pseudogene[1][2].

Other names: Retinoblastoma binding protein 6 pseudogene 1RBBP6P1

Mechanism of action

None (not druggable; no mechanism of action)

Biological functions

None (does not produce a functional protein; may have limited regulatory RNA roles, but this is not established)

Disease associations

None definitive (no disease associations reported for the pseudogene; functional RBBP6 protein is associated with cancer, but not this pseudogene)

Safety considerations

None (not a therapeutic target, no safety concerns)

Interacting drugs

None (no drugs interact with this pseudogene)

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on Retinoblastoma binding protein 6 pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoblastoma binding protein 6 pseudogene (null).

Explore the full profile